Home » Stocks » EKSO

Ekso Bionics Holdings, Inc. (EKSO)

Stock Price: $5.18 USD 0.16 (3.19%)
Updated May 14, 2021 4:00 PM EDT - Market closed
After-hours: $5.17 -0.01 (-0.19%) May 14, 7:48 PM
Market Cap 65.43M
Revenue (ttm) 9.33M
Net Income (ttm) -16.96M
Shares Out 10.75M
EPS (ttm) -2.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 14
Last Price $5.18
Previous Close $5.02
Change ($) 0.16
Change (%) 3.19%
Day's Open 5.05
Day's Range 5.05 - 5.33
Day's Volume 94,683
52-Week Range 2.83 - 14.98

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Ekso Bionics (EKSO) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front

1 day ago - Zacks Investment Research

BLKB, CTXS, EKSO, FHI, and GCI have been added to the Zacks Rank #5 (Strong Sell) List on May 5, 2021

Other stocks mentioned: BLKB, CTXS, FHI, GCI
1 week ago - Zacks Investment Research

Shares of Ekso Bionics Holdings (NASDAQ:EKSO) increased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share rose 22.73% year over year to ($0.34), which m...

2 weeks ago - Benzinga

RICHMOND, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today report...

2 weeks ago - GlobeNewsWire

Ekso Bionics (EKSO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 weeks ago - Zacks Investment Research

RICHMOND, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will...

3 weeks ago - GlobeNewsWire

Ekso Bionics (EKSO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the ...

1 month ago - Zacks Investment Research

RICHMOND, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announ...

2 months ago - GlobeNewsWire

Shares of Ekso Bionics Holdings (NASDAQ:EKSO) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 1100.00% over the past year to ($0.48), w...

2 months ago - Benzinga

On Thursday, February 25, Ekso Bionics Holdings (NASDAQ:EKSO) will report its last quarter's earnings. Here is Benzinga's preview of the company's release.

2 months ago - Benzinga

RICHMOND, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will ...

2 months ago - GlobeNewsWire

RICHMOND, Calif., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today announ...

3 months ago - GlobeNewsWire

Ekso Bionics Holdings Inc (NASDAQ: EKSO) has increased the size of the previously announced public offering to 3.9 million common shares at $10.25 per share, raising around $40 million in gross proceeds...

3 months ago - Benzinga

RICHMOND, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today announ...

3 months ago - GlobeNewsWire

RICHMOND, Calif., Feb. 08, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (“Ekso Bionics”), an industry leader in exoskeleton technology for medical and industrial use, today announ...

3 months ago - GlobeNewsWire

Science fiction collides with reality, as exoskeletons become a real-world device with a number of applications. The post 2 Science-Fiction Stocks to Play This Emerging Megatrend appeared first on Inves...

Other stocks mentioned: RWLK
3 months ago - InvestorPlace

RICHMOND, Calif., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced preliminary t...

4 months ago - GlobeNewsWire

RICHMOND, Calif., Dec. 30, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announc...

4 months ago - GlobeNewsWire

RICHMOND, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today announc...

6 months ago - GlobeNewsWire

Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q3 2020 Results - Earnings Call Transcript

6 months ago - Seeking Alpha

RICHMOND, Calif., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today reporte...

6 months ago - GlobeNewsWire

A c utting-edge endurance-boosting assistive device , E VO is designed to reduce the risk of repetitive or fatigue-related injuries for construction workers and other industrial employees

6 months ago - GlobeNewsWire

RICHMOND, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it will ...

6 months ago - GlobeNewsWire

RICHMOND, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that Jack ...

8 months ago - GlobeNewsWire

RICHMOND, Calif., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”) , an industry leader in exoskeleton technology for medical and industrial use, today un...

8 months ago - GlobeNewsWire

Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q2 2020 Results - Earnings Call Transcript

9 months ago - Seeking Alpha

Ekso Bionics (EKSO) delivered earnings and revenue surprises of 0.00% and 22.38%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

9 months ago - Zacks Investment Research

Ekso Bionics (EKSO) Q2 earnings are expected to have been boosted by its recent efforts to grow virtual connectivity with customers and to reduce costs.

9 months ago - Zacks Investment Research

RICHMOND, Calif., July 23, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that it wil...

9 months ago - GlobeNewsWire

WASHINGTON and RICHMOND, Calif., July 09, 2020 (GLOBE NEWSWIRE) -- The Army Distaff Foundation (ADF) , a non-profit charity in Washington, D.C., which operates Knollwood Military Life Plan  Community...

10 months ago - GlobeNewsWire

Ekso Bionics Holdings (NASDAQ: EKSO) shares were trading higher Friday on continued strength after the company received FDA clearance to market its EksoNR robotic exoskeleton.

10 months ago - Benzinga

Ekso Bionics (EKSO) news for Thursday concerning approval from the FDA for one of its devices has EKSO stock soaring higher.

10 months ago - InvestorPlace

Shares of Ekso Bionics Holdings Inc. EKSO, 130.85% soared Thursday, after the company said it has received 501 clearance from the U.S. Food and Drug Administration to market its EksoNR robotic exoskelet...

10 months ago - Market Watch

RICHMOND, Calif., June 25, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”) , an industry leader in exoskeleton technology for medical and industrial use, today ann...

10 months ago - GlobeNewsWire

Ekso Bionics (EKSO) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

10 months ago - Zacks Investment Research

RICHMOND, Calif., June 10, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today annou...

11 months ago - GlobeNewsWire

RICHMOND, Calif., June 08, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today annou...

11 months ago - GlobeNewsWire

Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies

11 months ago - GlobeNewsWire

RICHMOND, Calif., May 20, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today report...

11 months ago - GlobeNewsWire

Wall Street sell-side analysts are positive about Ekso Bionics Holdings Inc (NASDAQ:EKSO) and Entasis Therapeutics Holdings Inc (NASDAQ:ETTX), even though their holdings have lost more than 59% over the...

Other stocks mentioned: ETTX
11 months ago - GuruFocus

Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

RICHMOND, Calif., March 24, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (the “Company”) (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced tha...

1 year ago - GlobeNewsWire

Ekso Bionics Holdings, Inc. (EKSO) CEO Jack Peurach on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

RICHMOND, Calif., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced a collaboration with...

1 year ago - GlobeNewsWire

RICHMOND, Calif., Dec. 20, 2019 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today annou...

1 year ago - GlobeNewsWire

RICHMOND, Calif., Dec. 20, 2019 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced it signed a distribu...

1 year ago - GlobeNewsWire

RICHMOND, Calif., Dec. 19, 2019 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an industry leader in exoskeleton technology for medical and industrial use, today annou...

1 year ago - GlobeNewsWire

Ekso Bionics Holdings Inc. (EKSO) CEO Jack Peurach on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

RICHMOND, Calif., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), a leading developer of exoskeletons for medical and industrial use, today announced that Jack Peurach, ...

1 year ago - GlobeNewsWire

About EKSO

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the United States and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, sells, and rents exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, sells, and rents exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. Ekso Bionics Holdings, Inc. has a license agreement ... [Read more...]

Industry
Medical Instruments & Supplies
Founded
2005
CEO
Nathan Harding
Employees
39
Stock Exchange
NASDAQ
Ticker Symbol
EKSO
Full Company Profile

Financial Performance

In 2020, EKSO's revenue was $8.88 million, a decrease of -36.18% compared to the previous year's $13.92 million. Losses were -$15.83 million, 30.4% more than in 2019.

Financial Statements

Analyst Forecasts

According to 2 analysts, the average rating for EKSO stock is "Buy." The 12-month stock price forecast is 10.00, which is an increase of 93.05% from the latest price.

Price Target
$10.00
(93.05% upside)
Analyst Consensus: Buy